Imerslund-Grasbeck syndrome (IGS) is a hereditary health issue notably impacting Border Collie puppies in the United States, with genetic markers detected in roughly 7-8% of the breed. This autosomal recessive disorder disrupts the proper absorption of vitamin B12 (cobalamin), resulting in anemia and related health problems. Ethical breeders actively utilize genetic screening to minimize the spread of IGS within the breed.
IGS arises from a mutation in the CUBN gene, which is crucial for absorbing vitamin B12 in the small intestine. Without adequate absorption, dogs, especially Border Collies, may present symptoms starting from puppyhood, although some cases manifest later. Typical signs include poor weight gain, extreme fatigue, seizures, gastrointestinal issues such as vomiting and diarrhea, anemia, and proteinuria (protein detected in urine) despite otherwise normal kidney function.
A deficiency in vitamin B12 impairs the body's ability to produce red blood cells, causing a non-regenerative type of anemia where the body fails to replenish its blood cells. Puppies affected by IGS may also experience neutropenia (low white blood cell levels), reduced appetite, frequent urination, and overall failure to thrive. Early detection and treatment significantly enhance the pet’s wellbeing.
IGS is inherited through an autosomal recessive pattern, meaning a Border Collie must inherit two defective copies of the gene (one from each parent) to be affected. Based on genetic testing, dogs fall into three categories:
Breeding pair combinations yield the following possible genetic outcomes for offspring:
Confirming your dog's genetic status via DNA testing is essential for disease management and responsible breeding decisions. Testing can be performed through blood samples, cheek swabs, or dewclaw clippings, with several U.S. veterinary genetic laboratories offering reliable assays for IGS-associated CUBN gene mutations. The American Kennel Club and veterinary genetics organizations recommend these tests to help breeders prevent affected litters.
Although no cure exists, lifelong vitamin B12 supplementation through injections or oral administration bypasses the absorption problem in the intestine, effectively managing clinical signs. Routine veterinary monitoring and care allow affected Border Collies to lead comfortable lives. Prompt treatment notably improves neurological and systemic symptoms.
To lower IGS prevalence, breeders should avoid mating two carriers or affected dogs. Using genetic testing results informs breeding choices, preserving the breed’s health and quality of life over generations. Prospective Border Collie owners in the U.S. are urged to find reputable breeders who utilize genetic screening for this and other hereditary conditions, ensuring healthier puppies.
Imerslund-Grasbeck syndrome is a serious but treatable genetic disorder in Border Collies caused by a mutation affecting vitamin B12 absorption. Early and accurate diagnosis through genetic testing paired with responsible breeding strategies are crucial to control its impact. Though lifelong vitamin B12 supplementation is needed, dogs affected by IGS can enjoy improved health and longevity. Educated breeders and owners play a pivotal role in keeping this condition in check in the U.S. Border Collie population.